Published in Mediators Inflamm on February 22, 2017
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature (2007) 7.82
FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res (2006) 5.60
SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J (2001) 3.55
IL-12 family cytokines: immunological playmakers. Nat Immunol (2012) 3.12
Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr (1988) 3.10
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol (2007) 2.82
Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol (2009) 1.89
Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology (1994) 1.72
IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines. PLoS One (2012) 1.49
Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. Obes Res (2003) 1.33
Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des (2011) 1.32
Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology (2011) 1.25
Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35. Diabetes (2012) 1.21
The plasticity of regulatory T cell function. J Immunol (2011) 1.03
Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol (2012) 1.01
Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr (2010) 0.99
Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques. Am J Pathol (2009) 0.93
Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J (2016) 0.93
Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases. PLoS One (2012) 0.92
Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. Nat Med (2012) 0.91
Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population. Hum Immunol (2011) 0.86
Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance. Cardiovasc Diabetol (2015) 0.84
The modulation of endoplasmic reticulum stress by chemical chaperone upregulates immune negative cytokine IL-35 in apolipoprotein E-deficient mice. PLoS One (2014) 0.83
Association study of interleukin-12A gene polymorphisms with Graves' disease in two Chinese populations. Clin Endocrinol (Oxf) (2011) 0.82
Epstein-Barr virus-induced gene 3 (EBI3) polymorphisms and expression are associated with susceptibility to pulmonary tuberculosis. Tuberculosis (Edinb) (2015) 0.81
Association between polymorphisms of interleukin 12 and rheumatoid arthritis associated biomarkers in a Chinese population. Cytokine (2015) 0.80
Association of IL-12A and IL-12B polymorphisms with Alzheimer's disease susceptibility in a Han Chinese population. J Neuroimmunol (2014) 0.78
Association between polymorphisms in FOXP3 and EBI3 genes and the risk for development of allergic rhinitis in Chinese subjects. Hum Immunol (2012) 0.78
Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study. Immunobiology (2016) 0.77
Some polymorphisms in Epstein-Barr virus-induced gene 3 modify the risk for chronic rhinosinusitis. Am J Rhinol Allergy (2013) 0.77
Protective role of Interleukin 27 (IL-27) gene polymorphisms in patients with ulcerative colitis. Immunol Lett (2016) 0.76
The HIF1A rs2057482 polymorphism is associated with risk of developing premature coronary artery disease and with some metabolic and cardiovascular risk factors. The Genetics of Atherosclerotic Disease (GEA) Mexican Study. Exp Mol Pathol (2014) 0.81
The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. J Atheroscler Thromb (2012) 0.81
Interleukin-17A gene haplotypes are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study. PLoS One (2015) 0.81
Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population. Exp Mol Pathol (2014) 0.77
Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting. Exp Mol Pathol (2014) 0.77
Association of the C-type lectin-like domain family-16A (CLEC16A) gene polymorphisms with acute coronary syndrome in Mexican patients. Immunol Lett (2014) 0.76
The variant rs8048002 T>C in intron 3 of the MHC2TA gene is associated with risk of developing acute coronary syndrome. Cytokine (2014) 0.76
HIF1A (rs11549465) and AKNA (rs10817595) Gene Polymorphisms Are Associated with Primary Sjögren's Syndrome. Biomed Res Int (2017) 0.75
PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study. Immunobiology (2016) 0.75
The NLRP3 and CASP1 gene polymorphisms are associated with developing of acute coronary syndrome: a case-control study. Immunol Res (2017) 0.75
Receptor-interacting protein 2 (RIP2) gene polymorphisms are associated with increased risk of subclinical atherosclerosis and clinical and metabolic parameters. The Genetics of Atherosclerotic Disease (GEA) Mexican study. Exp Mol Pathol (2016) 0.75
The interleukin-1β-511 T>C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients. Immunol Lett (2015) 0.75
Association of interleukin-10 polymorphisms with risk factors of Alzheimer's disease and other dementias (SADEM study). Immunol Lett (2016) 0.75
Association of the suppressor of cytokine signaling 1 (SOCS1) gene polymorphisms with acute coronary syndrome in Mexican patients. Mol Immunol (2014) 0.75
The MHC2TA 1614 C>G gene polymorphism is associated with risk of developing acute coronary syndrome. Mol Immunol (2013) 0.75
Protective role of DDAH2 (rs805304) gene polymorphism in patients with myocardial infarction. Exp Mol Pathol (2014) 0.75
The T>A (rs11646213) gene polymorphism of cadherin-13 (CDH13) gene is associated with decreased risk of developing hypertension in Mexican population. Immunobiology (2016) 0.75